Document is current
Any future updates will be listed below
-
Authors
Schmitt, Janika
Poole, Emma
Groves, Ian https://orcid.org/0000-0001-8882-6701
Owen, David J https://orcid.org/0000-0002-8351-6322
Graham, Stephen C https://orcid.org/0000-0003-4547-4034
Sinclair, John https://orcid.org/0000-0002-2616-9571
Kelly, Bernard T https://orcid.org/0000-0003-2666-6268
-
Funding
Funding for this research was provided by:
Wellcome Trust (WT 207455/Z/17/Z)
Wellcome Trust (098406/Z/12/B)
UKRI | Medical Research Council (MR/S00081X/1)
Deutsches Zentrum für Infektionsforschung (DZIF MD TI 07.003)
CIMR Flow Cytometry Core Facility
Cambridge NIHR BRC Cell Phenotyping Hub
- License Information
-
More Information
Article History
Received: 27 July 2023
Revised: 14 December 2023
Accepted: 21 December 2023
First Online: 29 January 2024
Disclosure and competing interests statement
: The University of Cambridge has filed a patent application related to this work.
: All research describing studies on primary human material with HCMV was assessed and approved by the Cambridge Local Research Ethics committee (reference 97/092). Informed consent was received from blood donors with the Cambridge Local Research Ethics committee and the Cambridge Internal Review Board. Cells were harvested from healthy adult donors.
